منابع مشابه
Lineage determination during haemopoiesis.
"How do cells differentiate into one type or another? is one of the most fundamental questions in cell biology and is also pertinent to the problem of cell transformation, which may often involve progenitor cells [1] and derangement of developmental processes. Commitment of haemopoietic progenitor cells to differentiation along at least five distinct pathways during haemopoiesis continues throu...
متن کاملTracing development of the dendritic cell lineage.
Sighting of magnetic Majorana fermions? Quantum spin liquids—materials whose magnetic spins do not settle into order even at absolute zero temperature—have long captured the interest of physicists. A particularly lofty goal is finding a material that can be described by the so-called Kitaev spin model, a network of spins on a honeycomb lattice that harbors Majorana fermions as its excitations. ...
متن کاملDNGR-ing the dendritic cell lineage.
Dendritic cells (DCs) are a group of functionally specialized antigensensing and antigen-presenting cells that initiate and orchestrate immunity. DCs are uniquely equipped to recognize pathogens, vaccines and self-antigens, and to instruct simultaneously the type, magnitude and specificity of immune responses. They are remarkably heterogeneous, and identifying different subsets on the basis of ...
متن کاملDendritic Cell Immunotherapy, the Next Step in Cancer Treatment
Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...
متن کاملDendritic Cell Immunotherapy, the Next Step in Cancer Treatment
Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Haematology
سال: 1997
ISSN: 0007-1048,1365-2141
DOI: 10.1046/j.1365-2141.1997.d01-2030.x